Analyst Price Target is $11.33
▼ -11.60% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for ClearPoint Neuro in the last 3 months. The average price target is $11.33, with a high forecast of $15.00 and a low forecast of $9.00. The average price target represents a -11.60% upside from the last price of $12.82.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in ClearPoint Neuro. This Buy consensus rating has held steady for over two years.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Read More
